Pharsight

Drugs that contain Carbinoxamine Maleate

1. Karbinal Er patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9522191 AYTU Modified release formulations containing drug—ion exchange resin complexes
Jun, 2027

(3 years from now)

US8062667 AYTU Modified release formulations containing drug-ion exchange resin complexes
Mar, 2029

(5 years from now)

Market Authorisation Date: 28 March, 2013

Treatment: NA

Dosage: SUSPENSION, EXTENDED RELEASE;ORAL

More Information on Dosage

KARBINAL ER family patents

Family Patents